684 related articles for article (PubMed ID: 12150525)
1. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
Kaplan DM; Hehar SS; Bance ML; Rutka JA
Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
[TBL] [Abstract][Full Text] [Related]
2. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
3. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
[TBL] [Abstract][Full Text] [Related]
4. Does intratympanic gentamicin treatment for Meniere's disease cause complete vestibular ablation?
Hone SW; Nedzelski J; Chen J
J Otolaryngol; 2000 Apr; 29(2):83-7. PubMed ID: 10819105
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
Helling K; Schönfeld U; Clarke AH
Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
[TBL] [Abstract][Full Text] [Related]
6. Intratympanic gentamicin injection for the treatment of Meniere's disease.
Youssef TF; Poe DS
Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
8. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
9. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
Ozluoglu LN; Akkuzu G; Ozgirgin N; Tarhan E
Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
[TBL] [Abstract][Full Text] [Related]
10. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
Kaplan DM; Nedzelski JM; Chen JM; Shipp DB
Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
[TBL] [Abstract][Full Text] [Related]
11. Presumed reduction of vestibular function in unilateral Menière's disease with aminoglycoside eardrops.
Bath AP; Walsh RM; Bance ML
J Laryngol Otol; 1999 Oct; 113(10):916-8. PubMed ID: 10664709
[TBL] [Abstract][Full Text] [Related]
12. Vestibular function at the end of intratympanic gentamicin treatment of patients with Ménière's disease.
Perez N; Rama-Lopez J
J Vestib Res; 2005; 15(1):49-58. PubMed ID: 15908740
[TBL] [Abstract][Full Text] [Related]
13. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
Perez N; Boleas MS; Martin E
Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
[TBL] [Abstract][Full Text] [Related]
14. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
15. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
Colletti V; Carner M; Colletti L
Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
Silverstein H; Isaacson JE; Olds MJ; Rowan PT; Rosenberg S
Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
[TBL] [Abstract][Full Text] [Related]
17. [Intratympanic gentamicin treatment for intractable Menière's disease].
Gilony D; Wolf M; Kronenberg J
Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
19. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
Carey J
Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
Atlas JT; Parnes LS
Am J Otol; 1999 May; 20(3):357-63. PubMed ID: 10337978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]